Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006097 · ClinicalTrials.gov registry record · Phase 1
Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006097 is a Phase 1 study that has completed, run by Boston Medical Center.
The verdict
NCT00006097, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of CC-1088 in treating patients who have chronic lymphocytic leukemia that has not responded to previous therapy.
Interventions
- DRUG CC-1088
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-08 |
| Est. Completion | 2005-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006097
The ClinicalTrials.gov registry entry for NCT00006097 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CC-1088 is the first listed.
NCT00006097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006097 about?
NCT00006097 is a clinical study titled "Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of CC-1088 in treating patients who have chronic lymphocytic leukemia that has not responded to previous therapy.
What is the current status of trial NCT00006097?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-08. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00006097?
The interventions under investigation include: CC-1088 (DRUG).
Who is sponsoring clinical trial NCT00006097?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.